{"id":84,"date":"2018-10-27T05:02:51","date_gmt":"2018-10-27T12:02:51","guid":{"rendered":"http:\/\/kinaseinhibitorlibrary.com\/?p=84"},"modified":"2022-01-13T16:31:30","modified_gmt":"2022-01-13T09:31:30","slug":"keratinocytes-treated-dce-acquired-cell-motility-prone","status":"publish","type":"post","link":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/2018\/10\/27\/keratinocytes-treated-dce-acquired-cell-motility-prone\/","title":{"rendered":"keratinocytes treated with DCE acquired cell motility and were more prone"},"content":{"rendered":"

As a direct consequence of this cytostatic effect, keratinocytes treated with DCE or CS acquired cell motility and were more prone to migrate in functional in vitro scratch-wound assays in response to IL-22. CS and DCE significantly accelerated closure also of untreated scratched cultures, with an efficacy similar to IL-22, indicating that their effect is likely exerted on pathways constitutively activated in keratinocytes. At molecular level, this latter result can be related to the up-regulation of EGFR and ERK1\/2, which notoriously are activated by mechanical injury and essential for keratinocyte migration during wound healing process. Also downregulation of p-AKT could be involved in the enhancement of wound closure, as its inhibition is known to accelerate the scratch closure and potentiate the scratch-dependent stimulation of EGF-type growth factor genes. In light of our findings, we can hypothesize the employment of DCE and CS in psoriasis might counteract the pro-inflammatory effects of IFN-c and IL-22 on keratinocytes, as well as to inhibit hyperproliferation in the psoriatic epidermis. Moreover, DCE and CS might revert the apoptosis-resistant phenotype, which is due to intrinsic and acquired alterations of psoriatic keratinocytes. Among alterations, the abnormal activation of the SOCS1-3\/ PI3K\/AKT and downstream anti-apoptotic NF-kB cascades play a pivotal role in rendering epidermis less susceptible to cytokineinduced apoptosis. While AKT seems to be only slightly Dalasetron Mesylate hydrate<\/a> downregulated by DCE or CS, NF-kB is strongly inhibited by serquiterpene from Saussurea lappa, and NF-kB inhibition by DCE is known to enhance TNF-a-induced apoptosis of cancer cells. In addition, DCE- and CS-based treatments might be therapeutically relevant also for other skin diseases characterized by uncontrolled proliferation and deficient apoptosis in keratinocytes, including non-melanoma skin cancers. Further studies using terpene lactones in vivo in experimental models of skin hyperproliferative diseases are Epinastine<\/a> necessary to unveil their therapeutic efficacy, as recently demonstrated for other murine models of inflammatory diseases.<\/p>\n","protected":false},"excerpt":{"rendered":"

As a direct consequence of this cytostatic effect, keratinocytes treated with DCE or CS acquired cell motility and were more prone to migrate in functional in vitro scratch-wound assays in response to IL-22. CS and DCE significantly accelerated closure also of untreated scratched cultures, with an efficacy similar to IL-22, indicating that their effect is … Continue reading keratinocytes treated with DCE acquired cell motility and were more prone<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/84"}],"collection":[{"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=84"}],"version-history":[{"count":1,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/84\/revisions"}],"predecessor-version":[{"id":85,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/84\/revisions\/85"}],"wp:attachment":[{"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=84"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=84"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/kinaseinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=84"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}